D.E. Shaw & Co
HCAT icon

D.E. Shaw & Co’s Health Catalyst HCAT Stock Holding History

D.E. Shaw & Co’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113,641
Closed -$272K – 4743
2025
Q4 		$272K Buy
113,641
+36,981
+48% +$101K ﹤0.01% 4200
2025
Q3 		$218K Buy
+76,660
New +$262K ﹤0.01% 4244
2025
Q2 		– Sell
-208,651
Closed -$945K – 4483
2025
Q1 		$945K Buy
208,651
+195,686
+1,509% +$1.04M ﹤0.01% 3119
2024
Q4 		$91.7K Sell
12,965
-79,341
-86% -$632K ﹤0.01% 4172
2024
Q3 		$751K Buy
92,306
+49,865
+117% +$360K ﹤0.01% 3468
2024
Q2 		$271K Buy
+42,441
New +$272K ﹤0.01% 3947

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's HCAT Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 113,641 shares — an estimated $272K sold.

D.E. Shaw & Co first reported a position in HCAT in Q2 2024 and held it in 6 quarters. The position peaked at $945K in Q1 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 113,641 Health Catalyst shares in Q1 2026, an estimated $272K.
  • D.E. Shaw & Co first reported a position in Health Catalyst in Q2 2024 and held it in 6 quarters.
  • D.E. Shaw & Co's Health Catalyst position peaked at $945K in Q1 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.